Stocks and Investing Stocks and Investing
Mon, July 8, 2024
Fri, July 5, 2024
Wed, July 3, 2024
Tue, July 2, 2024

Christopher Raymond Maintained (ABBV) at Buy and Held Target at $190 on, Jul 2nd, 2024


Published on 2024-10-28 12:13:30 - WOPRAI, Christopher Raymond
  Print publication without navigation


Christopher Raymond of Piper Sandler, Maintained "AbbVie Inc." (ABBV) at Buy and Held Target at $190 on, Jul 2nd, 2024.

Christopher has made no other calls on ABBV in the last 4 months.



There are 5 other peers that have a rating on ABBV. Out of the 5 peers that are also analyzing ABBV, 0 agree with Christopher's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Christopher


  • Louise Chen of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $200 on, Thursday, June 20th, 2024
  • Rajesh Kumar of "HSBC" Upgraded from Hold to Strong Buy and Held Target at $185 on, Wednesday, June 5th, 2024
  • Carter Gould of "Barclays" Maintained at Buy with Decreased Target to $187 on, Monday, April 29th, 2024
  • Evan David Seigerman of "BMO Capital" Maintained at Buy with Decreased Target to $180 on, Monday, April 29th, 2024
  • Vamil Divan of "Guggenheim" Maintained at Strong Buy with Increased Target to $190 on, Friday, March 22nd, 2024